OPC-61815 injection

DRUG2 trials

Sponsors

Otsuka Pharmaceutical Co., Ltd., Otsuka Beijing Research Institute

Conditions

Congestive Heart FailureHealthy Adult Male

Phase 1

OPC-61815 in Healthy Chinese Male Subjects

CompletedNCT05439148

Otsuka Beijing Research InstituteHealthy Adult Male

Start: 2022-06-30End: 2022-09-21Updated: 2023-10-13

Phase 3

Safety Trial of OPC-61815 Injection in Patients With Congestive Heart Failure Who Have Difficulty With or Are Incapable of Oral Intake

CompletedNCT03962101

Otsuka Pharmaceutical Co., Ltd.Congestive Heart Failure

Start: 2019-06-17End: 2020-06-30Updated: 2021-09-05